Word

MP MILLICENT PHARMA

Status

Registered

Status Code

700

Status Date

Tuesday, August 24, 2021

Serial Number

79273445

Registration Number

6458104

Registration Date

Tuesday, August 24, 2021

Mark Type

5000

Filing Date

Thursday, June 20, 2019

Published for Opposition

Tuesday, June 8, 2021

Trademark Owner History

Millicent Pharma Limited - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical and veterinary preparations, namely, contraceptive preparations and substances; sanitary preparations for medical purposes; sterilizing preparations; hormone replacement therapy preparations; dietetic foods adapted for medical or veterinary use; dietetic substances, namely, dietetic sugar and sugar substitutes for medical use, dietetic infusions for medical use, dietetic preparations for medical purposes, and dietetic beverages for medical purposes; food for babies; medicated supplements for foodstuffs for babies; dietary supplements for humans and animals; plasters for medical purposes; materials for dressings, namely, bandages for dressings, gauze for dressings, wadding for dressings, and transparent films for dressings; material for stopping teeth, dental wax; dietary supplements for humans and dietetic preparations adapted for medical purposes; dental preparations, namely, dental preparations for disclosing plaque and tartar on the teeth, anti-cavity dental coating preparations containing fluoride, dental varnish for use by dentists, dental compounds used in endodontic procedures, and dental abrasives; dental articles, namely, prefilled dental trays for applying dental compositions to teeth, materials for making dental impressions, materials for dental use for fillings, materials for dental crowns, materials for dental bridges, amalgams for dental purposes, dental sealants, dental resin cement, dental hemostatic paste, dental adhesives, medicated dental rinses, dental blanks, bonding and primer materials for dental purposes, and dental polish; dental veneers for use in dental restoration; anesthetics; analgesics; bone cement for surgical and orthopedic purposes; capsules for medicines, namely, capsules sold empty for pharmaceuticals; decongestant capsules; allergy capsules; medical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, enzyme preparations for medical purposes, and diagnostic preparations for medical purposes; medical and veterinary articles for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, surgical implants comprised of living tissue; pharmaceuticals, namely, for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; natural remedies, namely, natural remedy preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical dressings; medical coverings for dressings used to cover and treat wounds and burns; medical applicators for the treatment of wounds and burns; hygienic preparations and articles, namely, disinfectants for hygiene purposes and antiseptics; all-purpose deodorizing preparations for household, commercial and industrial use; air purifying preparations; absorbent articles for personal hygiene, namely, pants, sanitary pads and absorbents for incontinence; disinfectants; preparations for destroying vermin; fungicides; herbicides; pest control preparations, namely, insecticides and poisons for domestic and agricultural use; pest control articles, namely, freeze dried food bait for pest control purposes, and granular repellent for burrowing pests; drug delivery agents that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparations, namely, drug delivery agents in the form of tablets, capsules, suppositories, dissolvable films, and coatings for tablets; drug delivery agents consisting of compounds that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparations; drug delivery agents that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparations, namely, drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals

1 Active chemical ingredients for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemicals for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical additives for use in the manufacture of pharmaceuticals

10 Medical apparatus and instruments for use in the prevention, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dental apparatus and instruments, namely, dental drills, dental drill bits, milling apparatus for dental purposes, dental root files, sprayers for cleaning the teeth and gums, oral irrigators, dental clips, bite trays, dental impression trays, prophy angles, apex locators, intra-oral dental light systems, dental picks, dental operating lamps, prosthetic instruments for dental purposes, hemostats, forceps for dental technical purposes, and teeth protectors; implant bridges for dental purposes; implant abutments for dental purposes; orthodontic machines and instruments for dental purposes; veterinary apparatus and instruments for use in the prevention, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in animals; artificial limbs, eyes and teeth; bracelets for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes used in the testing, monitoring and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical products, namely, intravaginal drug delivery devices for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; medical products, namely, implantable subcutaneous drug delivery devices for hormone replacement therapy products; medical products, namely, intravaginal drug delivery devices for hormone replacement therapy products; intra vaginal ring for delivery of hormone replacement therapy products by a continuous release system; inhalers for medical use; hearing protection devices, namely, hearing protectors without the ability to reproduce or transmit sound; feeding aids, namely, disposable teats being pacifiers for babies and dishes adapted for feeding babies and children; pacifiers for babies; contraceptive devices, namely, condoms, intra-uterine contraceptive devices, diaphragms for contraception, and medical implants for contraceptive purposes; syringes for injections and for medical purposes; medical apparatus, namely, medical measuring apparatus, being those that can directly transmit data to a database, particularly thermometers for medical use, and pulse meters; medical apparatus for measuring respiratory rates and sleeping conditions; all parts and fittings of all the aforesaid goods

42 Medical research services in the field of or for use in the field of the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders pharmacological research services in the field of or for use in the field of the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; scientific and technological research services relating to viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

The mark consists of "MP" in stylized form, displayed so that the "M" and the "P" are at different angles, with the wording "MILLICENT PHARMA" to the right of "MP". The initial "M" is dark blue, the initial "P" is turquoise, and the wording "MILLICENT PHARMA" is black.
The color(s) dark blue, turquoise and black is/are claimed as a feature of the mark.
"PHARMA"

Trademark Events

Feb 20, 2022

Final Decision Transaction Processed By Ib

Feb 2, 2022

Final Disposition Notice Sent To Ib

Feb 2, 2022

Final Disposition Processed

Nov 24, 2021

Final Disposition Notice Created, To Be Sent To Ib

Aug 24, 2021

Registered-Principal Register

Jul 10, 2021

Teas Change Of Correspondence Received

Jul 10, 2021

Teas Change Of Domestic Representatives Address

Jul 10, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 10, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 8, 2021

Official Gazette Publication Confirmation E-Mailed

Jun 8, 2021

Published For Opposition

Jun 7, 2021

Notification Processed By Ib

May 23, 2021

Notification Of Possible Opposition - Processed By Ib

May 19, 2021

Notification Of Possible Opposition Sent To Ib

May 19, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

May 19, 2021

Notification Of Notice Of Publication E-Mailed

May 6, 2021

Approved For Pub - Principal Register

May 5, 2021

Notification Of Possible Opposition Sent To Ib

May 5, 2021

Notification Of Possible Opposition Created, To Be Sent To Ib

Mar 31, 2021

Teas/Email Correspondence Entered

Mar 30, 2021

Correspondence Received In Law Office

Mar 30, 2021

Teas Request For Reconsideration Received

Nov 19, 2020

Notification Of Final Refusal Emailed

Nov 19, 2020

Final Refusal E-Mailed

Nov 19, 2020

Final Refusal Written

Sep 25, 2020

Examiner's Amendment Entered

Sep 24, 2020

Assigned To Lie

Sep 24, 2020

Notification Of Examiners Amendment E-Mailed

Sep 24, 2020

Examiners Amendment E-Mailed

Sep 24, 2020

Examiners Amendment -Written

Aug 12, 2020

Teas/Email Correspondence Entered

Aug 11, 2020

Correspondence Received In Law Office

Aug 11, 2020

Teas Response To Office Action Received

Jun 11, 2020

Applicant/Correspondence Changes (Non-Responsive) Entered

Jun 11, 2020

Teas Change Of Correspondence Received

Jun 11, 2020

Teas Change Of Domestic Representatives Address

Jun 11, 2020

Attorney/Dom.Rep.Revoked And/Or Appointed

Jun 11, 2020

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 11, 2020

Teas Change Of Owner Address Received

Feb 28, 2020

Refusal Processed By Ib

Feb 11, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Feb 11, 2020

Refusal Processed By Mpu

Jan 19, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Jan 18, 2020

Non-Final Action Written

Jan 14, 2020

Non-Final Action (Ib Refusal) Withdrawn For Review

Dec 14, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Dec 13, 2019

Non-Final Action Written

Dec 13, 2019

Application Filing Receipt Mailed

Dec 9, 2019

Assigned To Examiner

Dec 9, 2019

New Application Office Supplied Data Entered In Tram

Dec 5, 2019

Sn Assigned For Sect 66a Appl From Ib